BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 28848067)

  • 1. Aiolos Overexpression in Systemic Lupus Erythematosus B Cell Subtypes and BAFF-Induced Memory B Cell Differentiation Are Reduced by CC-220 Modulation of Cereblon Activity.
    Nakayama Y; Kosek J; Capone L; Hur EM; Schafer PH; Ringheim GE
    J Immunol; 2017 Oct; 199(7):2388-2407. PubMed ID: 28848067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cereblon modulator iberdomide induces degradation of the transcription factors Ikaros and Aiolos: immunomodulation in healthy volunteers and relevance to systemic lupus erythematosus.
    Schafer PH; Ye Y; Wu L; Kosek J; Ringheim G; Yang Z; Liu L; Thomas M; Palmisano M; Chopra R
    Ann Rheum Dis; 2018 Oct; 77(10):1516-1523. PubMed ID: 29945920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Reprogramming Commits Differentiation of Human CD27
    Torigoe M; Iwata S; Nakayamada S; Sakata K; Zhang M; Hajime M; Miyazaki Y; Narisawa M; Ishii K; Shibata H; Tanaka Y
    J Immunol; 2017 Jul; 199(2):425-434. PubMed ID: 28626065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus.
    Rivellese F; Manou-Stathopoulou S; Mauro D; Goldmann K; Pyne D; Rajakariar R; Gordon P; Schafer P; Bombardieri M; Pitzalis C; Lewis MJ
    Lupus Sci Med; 2021 Mar; 8(1):. PubMed ID: 33727237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
    Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.
    Matyskiela ME; Zhang W; Man HW; Muller G; Khambatta G; Baculi F; Hickman M; LeBrun L; Pagarigan B; Carmel G; Lu CC; Lu G; Riley M; Satoh Y; Schafer P; Daniel TO; Carmichael J; Cathers BE; Chamberlain PP
    J Med Chem; 2018 Jan; 61(2):535-542. PubMed ID: 28425720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of CD72 expression on CD19
    Lyu M; Hao Y; Li Y; Lyu C; Liu W; Li H; Xue F; Liu X; Yang R
    Br J Haematol; 2017 Jul; 178(2):308-318. PubMed ID: 28419421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.).
    Gandhi AK; Kang J; Havens CG; Conklin T; Ning Y; Wu L; Ito T; Ando H; Waldman MF; Thakurta A; Klippel A; Handa H; Daniel TO; Schafer PH; Chopra R
    Br J Haematol; 2014 Mar; 164(6):811-21. PubMed ID: 24328678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients.
    Rodríguez-Bayona B; Ramos-Amaya A; Pérez-Venegas JJ; Rodríguez C; Brieva JA
    Arthritis Res Ther; 2010; 12(3):R108. PubMed ID: 20525218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood CD27+ IgG+ B cells rapidly proliferate and differentiate into immunoglobulin-secreting cells after exposure to low CD154 interaction.
    Fecteau JF; Roy A; Néron S
    Immunology; 2009 Sep; 128(1 Suppl):e353-65. PubMed ID: 19016905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus.
    Shirota Y; Yarboro C; Fischer R; Pham TH; Lipsky P; Illei GG
    Ann Rheum Dis; 2013 Jan; 72(1):118-28. PubMed ID: 22858586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus.
    Eilertsen GØ; Nossent JC
    Lupus; 2014 Nov; 23(13):1383-91. PubMed ID: 25057039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAFF system expression in double negative 2, activated naïve and activated memory B cells in systemic lupus erythematosus.
    Álvarez Gómez JA; Salazar-Camarena DC; Román-Fernández IV; Ortiz-Lazareno PC; Cruz A; Muñoz-Valle JF; Marín-Rosales M; Espinoza-García N; Sagrero-Fabela N; Palafox-Sánchez CA
    Front Immunol; 2023; 14():1235937. PubMed ID: 37675114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus.
    Wei C; Anolik J; Cappione A; Zheng B; Pugh-Bernard A; Brooks J; Lee EH; Milner EC; Sanz I
    J Immunol; 2007 May; 178(10):6624-33. PubMed ID: 17475894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral CD24hi CD27+ CD19+ B cells subset as a potential biomarker in naïve systemic lupus erythematosus.
    Jin L; Weiqian C; Lihuan Y
    Int J Rheum Dis; 2013 Dec; 16(6):698-708. PubMed ID: 24286662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation.
    Joo H; Coquery C; Xue Y; Gayet I; Dillon SR; Punaro M; Zurawski G; Banchereau J; Pascual V; Oh S
    J Exp Med; 2012 Jul; 209(7):1335-48. PubMed ID: 22689824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased frequency of a unique spleen tyrosine kinase bright memory B cell population in systemic lupus erythematosus.
    Fleischer SJ; Giesecke C; Mei HE; Lipsky PE; Daridon C; Dörner T
    Arthritis Rheumatol; 2014 Dec; 66(12):3424-35. PubMed ID: 25156507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
    Sarantopoulos S; Stevenson KE; Kim HT; Cutler CS; Bhuiya NS; Schowalter M; Ho VT; Alyea EP; Koreth J; Blazar BR; Soiffer RJ; Antin JH; Ritz J
    Blood; 2009 Apr; 113(16):3865-74. PubMed ID: 19168788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal expression of BAFF and its receptors in peripheral blood and skin lesions from systemic lupus erythematosus patients.
    Chen Y; Yang M; Long D; Li Q; Zhao M; Wu H; Lu Q
    Autoimmunity; 2020 Jun; 53(4):192-200. PubMed ID: 32157911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.